Catherine Lumley

Catherine Lumley

Auto-generated profile, based on publicly available information

Catherine Lumley

Department of Otolaryngology/Head and Neck Surgery, University of North Carolina School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
DFDouglas R. Farquhar
Douglas R. Farquhar
MMMaheer M. Masood
Maheer M. Masood
NLNicholas R. Lenze
Nicholas R. Lenze
SSSiddharth Sheth
Siddharth Sheth
SPSamip N. Patel
Samip N. Patel
THTrevor G. Hackman
Trevor G. Hackman

11 December 2018 in Head & Neck
Verified
Journal Article
Closed access
PDF file
CLCatherine J. Lumley
Catherine J. Lumley
TKThomas M. Kaffenberger
Thomas M. Kaffenberger
SDSameer Desale
Sameer Desale
ETEshetu Tefera
Eshetu Tefera
CHChihun Jim Han
Chihun Jim Han
JMJessica H. Maxwell
Jessica H. Maxwell

11 March 2021 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
JWJessica Wilson
Jessica Wilson
CLCatherine Lumley
Catherine Lumley
Xianming TanXianming Tan
Xianming Tan
CSColette J Shen
Colette J Shen
ACAndrew Coniglio
Andrew Coniglio
BCBhishamjit S. Chera
Bhishamjit S. Chera
Objective: The objective of this study was to evaluate the clinical outcomes in a cohort of patients with early-stage oral tongue squamous cell carcinoma (OTSCC). Materials and Methods: We conducted a retrospective analysis of patients with pT1-T2N0 (American Joint Committee on Cancer [AJCC] seventh edition) OTSCC treated from 2000 to 2018. Two-year actuarial rates of local regional control, cancer-specific survival, and overall survival were calculated for the entire cohort and patients with/without adjuvant radiation. Results: Ninety-six patients met the criteria with a median follow-up of 4 years; 14 had adjuvant radiation, while 82 had surgery alone. Two-year local regional control was 82.7% (75.4% to 90.8%) for the entire cohort, 84.9% (77.8% to 93.2%) for surgery only, and 70.7% (50.2% to 99.6%) for patients with adjuvant radiation. Two-year progression-free survival was 82.7% (75.3% to 90.8%). Of the 20 patients with recurrence, 11 (55%) were successfully salvaged. Conclusion: Local regional recurrence remains modest in early-stage OTSCC, but salvage is possible with high survival rates. Level of Evidence: Level III—retrospective cohort study.